Attaya Suvannasankha, MD

Dr. Attaya Suvannasankha is a hematologist and medical oncologist who specializes in caring for people with multiple myeloma, a type of blood cancer. She leads the Multiple Myeloma Program within the Division of Hematology and Oncology at Indiana University School of Medicine and provides care through the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.

Dr.  Suvannasankha believes that the best care is built on trust, communication and partnership. She takes a personalized approach, working closely with each patient to understand their goals and guide them through complex treatment decisions. Her care blends compassion with the most up to date research, helping patients feel informed, supported and confident throughout their cancer journey.

What Dr. Suvannasankha Treats

• Multiple myeloma
• Relapsed or treatment resistant myeloma
• Bone and skeletal complications related to myeloma
• Blood cancers requiring advanced or clinical trial based treatments

Research & Clinical Expertise

In addition to caring for patients, Dr.  Suvannasankha is dedicated to improving outcomes for people with multiple myeloma. Her research focuses on understanding why myeloma can become resistant to treatment or return over time, with special attention to how the bone marrow environment supports disease growth.

She leads and participates in early and late phase clinical trials, offering eligible patients access to innovative therapies and combination treatments. Her research is closely connected to patient care, helping translate scientific discoveries into real world advances that shape modern myeloma treatment.

Why She Practices Medicine

Dr.  Suvannasankha chose oncology because she is deeply committed to helping patients and families navigate complex cancer diagnoses with clarity and hope. Her goal is to bridge scientific discovery and compassionate care—working toward longer lasting disease control and, ultimately, a cure for multiple myeloma.